<?xml version="1.0" encoding="utf-8" standalone="no"?>
<!DOCTYPE file
  SYSTEM 'wikixml.dtd'>
<file type="Article" date="2024-09-24T08:08:47Z" sourceCorpus="COVID-19" filename="67288169" title="DelNS1-2019-nCoV-RBD-OPT" url="https://en.wikipedia.org/wiki/DelNS1-2019-nCoV-RBD-OPT">
	<text>
		<segment id="id67288169">DelNS1-2019-nCoV-RBD-OPT is a COVID-19 vaccine developed by Beijing Wantai Biological, Xiamen University and the University of Hong Kong. It is administered as a single dose intranasal spray.

On 14 December 2022, the vaccine was listed by the National Health Commission of China as a secondary booster dose option for people who have completed their third doses of inactivated COVID-19 vaccines for 6 months or longer.

 References 















</segment>
	</text>
</file>
